INDUSTRY INDEX
Explore industries that sell products and services to the scientific community. Each profile maps key companies, target researcher segments, market size, and use cases.
96
INDUSTRIES
$4.2B
Acoustic and ultrasonic technology companies supply non-destructive evaluation instruments, diagnostic ultrasound transducers, and acoustic monitoring systems to aerospace, nuclear, petrochemical, and medical sectors. University acoustic engineering and physics departments advance phased array imaging algorithms, air-coupled transducer designs, and photoacoustic methods that NDT companies commercialize.
$390B
Advanced manufacturing fuses additive techniques, robotics, and AI-driven process control to make complex parts at scale. It recruits mechanical and materials engineers from academia and partners with university labs on metal printing and digital-factory research.
$65B
Advanced packaging and chiplets represent the semiconductor industry's response to the slowing of transistor scaling: disaggregating monolithic chips into smaller specialized dies that are integrated at the package level using high-density interconnects. The discipline draws on academic research in electrical engineering, materials science, and photonics — particularly work on through-silicon vias, wafer bonding, and co-packaged optics from university clean-room programs. Companies such as Ayar Labs and ASE Group are forming research partnerships with institutions that have fabrication facilities capable of prototyping new interconnect architectures. Academic intelligence enables packaging teams to monitor publication activity on die-to-die interface standards and thermal-management innovations, helping them identify collaborative partners and hire specialized engineers before competitors.
$430B
The aerospace and defense sector relies on academic engineering and applied-physics research for advances in propulsion, hypersonics, autonomy, and sensing. Primes and defense startups fund University Affiliated Research Centers, co-author on DARPA and AFRL programs, and recruit clearance-eligible PhDs through specialized pipelines. Because much of the work touches export control, identifying citizenship-eligible and clearance-ready researchers is a distinct prospecting challenge.
$24B
The agritech industry commercializes advances in plant genetics, soil microbiology, and precision agriculture, much of which originates in land-grant university research programs. Companies recruit heavily from plant-science and agronomy PhD pipelines and rely on sponsored research and field-trial collaborations to validate new traits and biologicals. The closest academic ties run through agricultural extension labs and crop-genomics centers.
$5.8B
AI drug discovery companies apply deep learning, generative models, and large-scale phenotypic imaging to compress preclinical timelines from years to months. They recruit computational chemistry PhDs from academic labs advancing molecular representation learning, protein structure prediction, and multi-task ADMET models, and they license training datasets from university bioactivity databases.
$76B
Analytical chemistry instrumentation supports quality control, environmental monitoring, food safety, and pharmaceutical development globally. Companies develop HPLC, GC, ICP-MS, and NMR instruments and consumables, relying on university analytical chemistry groups for method development innovations and application note partnerships.
$330B
Antibody discovery platforms generate therapeutic, diagnostic, and research-grade antibodies through display technologies, single B-cell sorting, and computational design. The industry heavily licenses phage display libraries and B-cell discovery workflows from university immunology groups, recruiting PhDs with deep in vitro selection expertise.
$210B
The autonomous-vehicle industry builds self-driving systems for ride-hailing, trucking, and delivery. It recruits ML and robotics researchers from academia and partners with university labs on perception, prediction, and safety-validation research.
$140B
The battery and energy-storage industry develops chemistries beyond lithium-ion for electric vehicles and the grid. It recruits electrochemists and materials scientists from academia and routinely spins technology out of university and national-lab research.
$1.9B
Bioinformatics tools handle the computational processing and interpretation of next-generation sequencing, proteomics, and imaging data. Commercial platforms license algorithms and pipelines developed by academic bioinformatics groups, often co-developing new analysis tools with university labs generating the largest and most complex biological datasets.
$820B
The biotech industry translates cutting-edge biological research into therapeutics, diagnostics, and research tools. It is the primary employer of PhD-trained scientists outside academia and maintains the closest ties to university research.
$25B
Carbon capture and removal builds engineered systems to pull CO2 from the air and industrial flues. The young industry recruits chemical engineers and materials scientists from universities and commercializes academic sorbent and process research.
$72B
Cardiovascular therapeutics address the leading cause of global mortality through lipid-lowering agents, heart failure drugs, and emerging gene-based interventions. Academic cardiovascular research groups generate foundational IP in PCSK9 biology, cardiac metabolism, and gene therapy delivery that biotech and pharma companies license for IND-enabling programs.
$14B
Cell therapy engineers living cells—predominantly T cells and NK cells—as therapeutic agents, with CAR-T programs for hematological cancers leading commercial adoption. The field recruits immunology and gene-editing PhDs and relies on university labs for novel receptor discovery, ipsc differentiation, and manufacturing process research.
$11B
Chemical biology applies small molecules and synthetic chemistry tools to interrogate biological processes with spatiotemporal precision. Academic chemical biology groups develop activity-based protein profiling probes, bioorthogonal reagents, and covalent inhibitor scaffolds that commercial reagent companies license and sell to the broader research community.
$5.7T
The chemicals and materials industry commercializes university research in polymer science, catalysis, and computational materials discovery into coatings, composites, and specialty chemicals. Major players maintain long-running sponsored-research relationships with university materials centers and recruit steadily from chemistry and chemical-engineering PhD programs. Increasingly, machine-learning-driven materials discovery has tightened the loop between academic computational chemists and industrial R&D pipelines.
$4.6B
Cleanroom technology companies design, build, and supply contamination-controlled manufacturing environments and consumables for pharmaceutical, semiconductor, aerospace, and biomedical device production. University aerosol science and pharmaceutical engineering groups advance particle behavior models, sampling methods, and surface decontamination protocols adopted into GMP contamination control programs.
$3.2B
Climate technology companies deploy and scale carbon removal, green hydrogen, and industrial decarbonization solutions. Academic research in atmospheric chemistry, electrochemistry, and geological carbon storage provides the fundamental science for sorbent discovery, ocean-based removal monitoring, and subsurface storage characterization that climate tech startups commercialize.
$68B
CROs manage Phase I–IV clinical programs for pharma and biotech sponsors: study design, patient recruitment, monitoring, data management, and regulatory submissions. Growing demand for decentralized trials and real-world evidence has created new roles for digital health researchers and biostatisticians.
$46B
Advanced composite materials—predominantly carbon fiber reinforced polymers—deliver structural performance unmatched by metals at a fraction of the weight, driving adoption in aerospace, wind energy, automotive, and sporting goods. University composites labs advance automated fiber placement, thermoplastic processing, and recyclable thermoset chemistries that companies license for next-generation products.
$7B
Computational drug discovery companies use physics-based simulations, machine learning, and large biological datasets to design novel drug candidates faster and at lower cost than traditional screening campaigns. The field is a direct commercialization of academic research in structural biology, quantum chemistry, and deep learning — disciplines that generated foundational tools like AlphaFold, FEP+, and variational autoencoders for molecular generation. Companies such as Schrödinger and Relay Therapeutics recruit computational chemists and ML researchers who have published on force-field parameterization, binding free-energy methods, or generative molecular models, often approaching them before their dissertations are finalized. Academic intelligence platforms let these companies continuously track relevant preprints and publication networks, mapping which university groups are producing the next generation of methods that could meaningfully shift hit rates in a given target class.
$82B
Contract research organizations (CROs) provide outsourced research services to pharma, biotech, and medical device companies. They are major employers of PhD-trained scientists and play a critical role in bringing therapies from bench to bedside.
$220B
Cosmetic ingredient companies develop and supply active compounds, emulsifiers, preservatives, UV filters, and specialty polymers to cosmetics and personal care formulators worldwide. Academic dermatology and biochemistry groups generate novel skin biology insights—microbiome interactions, barrier function, peptide-receptor activation—that ingredient companies license for new product claims and development.
$3.1B
Cryogenics and biobanking infrastructure supports drug discovery, cell therapy manufacturing, and biomedical research by preserving biological samples at ultra-low temperatures. As cell and gene therapy pipelines expand, companies require advanced cryopreservation protocols and DMSO-free media developed by academic cryobiology groups.
$25B
Cultivated meat companies grow animal muscle tissue directly from stem cells, aiming to produce conventional meat products without livestock farming. The science is grounded in academic cell biology, regenerative medicine, and food engineering — disciplines whose tools for myogenic differentiation, extracellular matrix synthesis, and perfusion bioreactor design were developed for therapeutic tissue engineering rather than food production. Companies like UPSIDE Foods and Mosa Meat recruit cell biologists and tissue engineers from university programs and hospital research institutes, adapting their expertise to food-grade manufacturing constraints. Academic intelligence lets cultivated-meat developers track publications on serum-free expansion media, scaffold biomechanics, and cost-reduction strategies for growth factors — critical inflection points where academic breakthroughs directly determine whether the industry can reach price parity with conventional meat at industrial scale.
$220B
Cybersecurity research defends systems against evolving threats through cryptography, secure systems, and ML-driven detection. It recruits computer scientists from academic security labs and collaborates on confidential computing and formal-verification research.
$6.1B
Deep sea and ocean technology companies develop remotely operated vehicles, autonomous underwater vehicles, acoustic sensors, and subsea instrumentation for oceanographic research, offshore energy, and seafloor mining. University ocean engineering and marine science departments pioneer novel propulsion systems, pressure-tolerant electronics, and acoustic communication protocols that industry licenses and deploys at commercial scale.
$160B
Defense electronics covers radar, electronic warfare, autonomy, and sensing systems for national security. It recruits engineers and physicists in RF and signal processing and works closely with university-affiliated research centers and DARPA programs.
$98B
The diagnostics and genomics industry depends on academic medical centers and university genomics labs to validate assays, supply clinical cohorts, and pioneer methods like single-cell and spatial sequencing. Companies recruit bioinformaticians and genomics PhDs and engage academic key opinion leaders to drive clinical adoption of new tests. Biobank access and sponsored biomarker research with university pathology departments are central to bringing diagnostics to market.
$820B
Digital health companies apply data science, machine learning, and connected devices to clinical care, population health management, and pharmaceutical evidence generation. The industry recruits from a wide range of academic disciplines — clinical informatics, epidemiology, biostatistics, and human-computer interaction — that are predominantly trained in university hospitals and public-health programs. Companies like Flatiron Health and Aetion have built their core real-world evidence platforms on methodologies originally developed in academic health economics and pharmaco-epidemiology. Academic intelligence helps digital health firms identify clinical researchers who are publishing on specific disease areas, EHR phenotyping methods, or wearable-sensor validation before those researchers transition to industry or get locked into competing partnerships, enabling faster and more targeted business development.
$210B
Drug delivery companies extend the therapeutic window and improve bioavailability of existing and novel APIs through lipid nanoparticles, polymer hydrogels, inhalation devices, and targeted delivery platforms. University pharmaceutical sciences departments are prolific IP generators for oral bioavailability enhancement, mucosal delivery, and brain-targeted carriers.
$8.3B
Electrochemical sensors and instruments measure chemical and biological analytes by transducing reactions at electrode-electrolyte interfaces into electrical signals. Academic electrochemistry groups develop new electrode materials, surface chemistries, and microfluidic cell architectures that underpin commercial glucose monitors, environmental sensors, and battery-testing instruments.
$4.8B
Electron microscopy instruments and services underpin structural biology, materials characterization, and semiconductor inspection. The cryo-EM revolution has made university EM cores pivotal partners for structural biology drug discovery, with instrument makers co-developing hardware and workflows with academic users pushing resolution limits.
$1.9T
Energy and cleantech companies translate breakthroughs in electrochemistry, catalysis, and plasma physics into batteries, fuels, fusion reactors, and carbon-capture systems. The sector draws talent and IP directly from university labs and DOE national laboratories, and many of its flagship startups began as academic spinouts. Sponsored research and pilot validation with university labs are core to de-risking new chemistries before scale-up.
$1.2B
Environmental genomics uses DNA extracted from environmental samples—water, soil, air—to survey biodiversity, detect invasive species, and monitor ecosystem health without collecting organisms. Companies commercializing eDNA surveys, metagenomics-based soil health indices, and metabarcoding kits license reference databases and sampling protocols developed by university ecology and conservation biology departments.
$14B
Environmental testing laboratories and technology companies detect pollutants, pathogens, and emerging contaminants in water, soil, air, and food, supporting regulatory compliance and environmental monitoring programs. University analytical chemistry and environmental engineering groups advance PFAS quantification, microplastic analysis, and eDNA monitoring methods that commercial labs standardize and deploy.
$3.9B
Epigenomics companies target chromatin-modifying enzymes—HATs, HDACs, methyltransferases—to reverse aberrant gene silencing in cancer and immune disorders. University chromatin biology labs are key IP sources for novel histone modification pathways, screening assays, and epigenetic biomarkers that companies incorporate into drug discovery programs.
$4.2B
Flow cytometry and high-content cell analysis instruments quantify cellular properties at single-cell resolution, making them essential for immunology, cancer biology, and clinical diagnostics. Instrument companies partner with university immunology cores and cancer centers to develop new fluorochrome panels, gating strategies, and rare-event detection workflows.
$75B
Food ingredient companies supply flavors, texturizers, emulsifiers, stabilizers, functional proteins, and bioactives to food and beverage manufacturers worldwide. University food science, nutrition, and biochemistry departments develop novel plant protein processing methods, microencapsulation platforms, and prebiotic structures that ingredient companies license for functional food applications.
$9.4T
The food science industry turns academic work in fermentation, flavor chemistry, and nutrition into alternative proteins, functional ingredients, and reformulated products. Companies fund university food-science departments for sensory and nutrition studies and recruit fermentation and food-engineering PhDs as the alternative-protein and precision-fermentation categories scale. Strain and process IP frequently originates in academic labs before being licensed into commercial production.
$3.9B
Forensic science companies supply DNA profiling kits, toxicology standards, trace evidence analysis tools, and informatics platforms to law enforcement laboratories and government forensic agencies. Academic forensic genetics, toxicology, and soil science groups develop new identification technologies—investigative genetic genealogy, pollen analysis, explosives trace detection—that companies license and commercialize.
$40B
Fusion energy companies are racing to commercialize controlled nuclear fusion by recruiting plasma physicists and nuclear engineers trained at national laboratories and research universities. The sector's core science — magnetohydrodynamics, high-temperature superconductors, and tritium breeding — is almost entirely rooted in decades of academic output from programs like MIT's PSFC and Princeton Plasma Physics Lab. Private ventures such as Commonwealth Fusion Systems and Helion are licensing university IP and staffing entire divisions with recently graduated PhDs. Academic intelligence helps recruiters identify authors on confinement, mirror-machine, and Z-pinch papers before they enter the general job market, compressing a notoriously long hiring cycle.
$95B
Gene therapy delivers genetic fixes for inherited and acquired diseases using viral vectors and genome editing. It recruits molecular biologists and bioengineers from academia and frequently licenses university-developed editing and delivery technologies.
$12B
Next-generation geothermal companies are moving beyond conventional hydrothermal fields to develop enhanced geothermal systems that can generate power almost anywhere by engineering fracture networks in hot dry rock. The sector recruits geoscientists, petroleum engineers retrained in subsurface heat flow, and drilling engineers — talent pools that overlap heavily with university earth-science and geoengineering programs. Quaise Energy is commercializing millimeter-wave vaporization drilling invented at MIT, illustrating how tightly the industry's frontier technology is tied to academic research. Academic intelligence helps geothermal developers track publications on reservoir stimulation, microseismic monitoring, and novel drilling approaches, enabling them to identify university partners and recruit specialized researchers before the larger oil-and-gas industry absorbs them.
$185B
The hydrogen economy encompasses the production, storage, transport, and conversion of hydrogen as a zero-carbon energy carrier, with applications in heavy industry, shipping, and long-duration grid storage. The sector's key bottlenecks — electrolyzer efficiency, catalyst durability, and hydrogen embrittlement in storage — are active university research problems that companies like Electric Hydrogen and H2Pro are working to commercialize. Disciplines recruited include electrochemistry, surface science, polymer engineering, and thermodynamics. Academic intelligence gives hydrogen companies the ability to track catalyst and membrane publications in real time, identifying researchers whose work could accelerate stack performance or reduce the cost of green hydrogen before those researchers are approached by incumbent industrial gas players.
$68B
Cancer immunotherapy harnesses the immune system to eliminate tumors, with checkpoint inhibitors, CAR-T cells, and cancer vaccines driving a transformation in oncology. Academic tumor immunology groups discover novel checkpoint targets, characterize immunosuppressive mechanisms, and develop neoantigen platforms that biotech companies license for clinical development.
$190B
Industrial biotechnology engineers microbes and enzymes to make chemicals, materials, and fuels sustainably. The sector recruits metabolic engineers and synthetic biologists from academia and frequently builds on university pathway-engineering research.
$68B
Industrial coatings companies formulate and supply protective finishes for infrastructure, marine vessels, oil and gas assets, and industrial machinery. Academic polymer chemistry and corrosion engineering groups develop low-VOC formulations, bio-based binder systems, and corrosion inhibitor mechanisms that coatings companies license to meet performance and environmental standards.
$9B
Lab automation companies are transforming bench science by replacing manual pipetting, incubation, and data recording with robotic systems, orchestration software, and AI-driven experimental planning. The sector recruits from chemistry, biology, robotics engineering, and computer science programs — drawing especially on researchers who have built or published on self-driving laboratory platforms, high-throughput screening infrastructure, or Bayesian optimization in experimental science. Platforms like Opentrons and Synthace are designed by scientists who moved from academic labs frustrated by reproducibility and throughput limits, and the companies continue to co-develop features with university and pharma lab partners. Academic intelligence helps automation vendors identify early-career researchers who are publishing on workflow automation or active-learning experiments, enabling targeted outreach for technical sales, scientific advisory roles, and collaborative development programs.
$78B
The laboratory instruments industry manufactures the physical tools of scientific research, from microscopes and mass spectrometers to sequencers and flow cytometers. Researchers are both the end users and key influencers in purchasing decisions.
$28B
Marine and blue-tech companies are commercializing the ocean as a platform for energy production, environmental monitoring, deep-sea resource extraction, and carbon removal. The industry draws on academic expertise in physical oceanography, marine biology, naval architecture, and underwater acoustics — disciplines concentrated in coastal research universities and institutions like WHOI, Scripps, and NOC. Companies like Saildrone and Running Tide are spinning out technology developed through federally funded ocean research programs and staffing their science teams with oceanographers who publish on ocean-atmosphere exchange, biogeochemical cycling, and autonomous sensing. Academic intelligence allows blue-tech firms to monitor publication activity across these disciplines, identify researchers before they graduate, and map institutional collaboration opportunities in a field where scientific credibility is essential for regulatory approval.
$6.5B
Mass spectrometry-based proteomics and metabolomics have become cornerstones of clinical biomarker discovery, pharmaceutical quality control, and systems biology. Leading instrument makers partner with university proteomics centers for application development, often co-authoring methods papers that demonstrate new hardware capabilities in high-impact biological contexts.
$8.7B
Materials characterization service labs apply a battery of analytical techniques—electron microscopy, X-ray diffraction, spectroscopy, and mechanical testing—to support R&D, quality assurance, and failure investigation. They rely on university materials science programs for novel characterization method development and training the analytical scientists who staff commercial testing operations.
$5B
Materials informatics applies machine learning and simulation to discover and optimize materials far faster than trial and error. It recruits computational materials scientists from academia and partners with university groups generating training data and models.
$595B
The medical device industry develops instruments, implants, and diagnostics that improve patient outcomes. It relies heavily on academic research in biomedical engineering, materials science, and clinical medicine to drive innovation.
$105B
Metabolic disorder companies develop drugs for type 2 diabetes, obesity, NASH, and dyslipidemia, with GLP-1 receptor agonists currently driving record revenues. Academic metabolic research groups at medical schools provide the mechanistic insights, mouse models, and biomarker pipelines that fuel the next generation of metabolic targets.
$2.3B
Microbiome therapeutics target the trillions of microorganisms colonizing the human gut, skin, and other niches to treat metabolic, inflammatory, and neurological conditions. The industry recruits metagenomics PhDs and licenses gnotobiotic mouse model platforms and strain collections from academic microbiome centers.
$14B
Microelectronics and MEMS fabrication companies manufacture pressure sensors, accelerometers, microphones, gyroscopes, and microfluidic devices using silicon microfabrication. University clean-room facilities at MIT, Stanford, and ETH are key innovation sources, with companies regularly licensing novel process flows, sensor architectures, and packaging techniques developed in academic fabs.
$200B
Mining technology modernizes extraction with AI exploration, sensor-based sorting, and autonomous equipment, sharpened by demand for battery metals. It recruits geoscientists and machine-vision researchers and partners with university geology and mineral-processing departments.
$24B
mRNA therapeutics harness synthetic messenger RNA to encode proteins from vaccine antigens to intracellular enzymes, enabling rapid development cycles and personalized dosing. Lipid nanoparticle delivery chemistry, cap analogue chemistry, and nucleoside modification are the key academic IP generators the industry actively licenses.
$9.2B
Nanomedicine applies nanoscale drug carriers such as LNPs, polymeric micelles, and dendrimers to improve the delivery, pharmacokinetics, and tumor accumulation of small molecules, nucleic acids, and biologics. The siRNA delivery revolution drew heavily from university polymer chemistry and biophysics labs whose LNP and conjugate chemistry innovations are now licensed worldwide.
$120B
The nanotechnology industry engineers matter at the 1–100 nm scale, enabling applications across drug delivery, electronics, energy storage, catalysis, and advanced coatings. Companies recruit researchers with expertise in scanning probe microscopy, colloidal synthesis, and quantum confinement, regularly licensing nanoparticle platforms from university spin-offs.
$12B
Neurodegenerative disease companies develop treatments for Alzheimer's, Parkinson's, ALS, and frontotemporal dementia, where academic research provides the majority of validated targets, biomarkers, and disease models. The field recruits neuroscientists from top medical schools and licenses iPSC neuron platforms, CRISPR screening results, and biomarker assays from university partners.
$20B
Neurotech builds interfaces that read from and write to the nervous system for medical and human-augmentation applications. It recruits neuroscientists and engineers from academia and partners with university labs on decoding algorithms and implantable devices.
$430B
Nuclear energy is being reinvented through small modular reactors and private fusion ventures pursuing clean baseload power. The field recruits nuclear engineers, materials scientists, and plasma physicists, with deep ties to national labs and university research reactors.
$6.8B
Nuclear medicine uses radioactive isotopes attached to targeting molecules for diagnosis via PET and SPECT and therapy through targeted radionuclide therapy of cancer and neurological disease. University radiochemistry and medical physics departments develop new chelation chemistries, targeting peptides, and radiolabeling automation platforms that companies license for clinical radiopharmaceutical pipelines.
$55B
Oncology diagnostics develops blood-based and genomic tests to detect and monitor cancer earlier and more precisely. It recruits molecular biologists and bioinformaticians from academia and partners with cancer centers on biomarker and assay research.
$5.9B
Optical microscopy instruments span from widefield epifluorescence to super-resolution STED and light-sheet systems, enabling visualization of cellular processes at nanometer spatial and millisecond temporal resolution. Instrument companies partner with academic labs pushing the frontiers of live-cell imaging, phase contrast, and fluorescence labeling chemistry.
$52B
Optoelectronics companies manufacture lasers, LEDs, photodetectors, and photonic integrated circuits for communications, LiDAR, medical imaging, and displays. University photonics departments develop novel III-V growth techniques, photonic crystal designs, and on-chip integration schemes that semiconductor companies license for next-generation product lines.
$1.5T
The pharmaceutical industry is the largest commercial consumer of academic research, investing over $200 billion annually in R&D. Companies actively seek academic collaborations for early-stage drug discovery, biomarker validation, and clinical expertise.
$780B
Photonics underpins data-center interconnects, LiDAR, imaging, and optical computing through devices that manipulate light on-chip. The field recruits optical physicists and frequently commercializes university inventions in integrated photonics and metasurfaces.
$650B
The polymer industry synthesizes and processes macromolecular materials for packaging, electronics, automotive, biomedical, and construction sectors. Academic polymer groups generate IP in controlled radical polymerization, recyclable thermosets, and biobased polymers that companies license for commercial scale-up.
$130B
Precision agriculture applies genomics, microbiology, robotics, and data science to boost yields while cutting inputs. The sector recruits plant scientists and agronomists from universities and partners on field trials of new seeds, microbes, and sensing systems.
$4.2B
Protein engineering applies directed evolution and computational design to create novel enzymes, binding proteins, and biologics with precisely tuned properties. AlphaFold2-enabled rational design has accelerated collaborations between academic structural biology groups and industrial protein scientists seeking optimized catalysts and therapeutic scaffolds.
$65B
The quantum computing industry races to build machines that exploit superposition and entanglement for previously intractable problems. It draws heavily on academic physics labs, often spinning out directly from university research groups and competing fiercely for PhD-trained hardware talent.
$230B
Rare disease therapeutics address conditions affecting fewer than 200,000 patients using gene therapy, enzyme replacement, and RNA modulation. Orphan drug designation and premium pricing support returns despite small patient pools, making this industry highly motivated to partner with academic researchers who own rare disease cohorts, biobanks, and foundational mechanistic IP.
$18B
The scientific recruiting industry connects trained researchers with positions in industry, government, and academia. With over 80% of STEM PhDs eventually leaving academic tenure tracks, this sector serves a massive and growing market.
$26B
Regenerative medicine replaces or repairs damaged tissues using scaffolds, cells, and growth factors. Academic biomaterials and stem cell groups are key IP sources for decellularized ECM products, injectable hydrogels, and organoid platforms that companies license for wound care, orthopedics, and organ repair applications.
$210B
The robotics industry is converging with AI to build general-purpose humanoid and mobile robots for logistics, manufacturing, and services. It hires heavily from academic robotics and ML labs, with several leading companies founded directly by university researchers.
$28B
The scientific publishing industry sells journals, databases, and research-analytics tools to the same academic researchers who author and review its content. Identifying productive, well-funded authors is essential for both editorial recruitment and product sales, since lab heads influence institutional subscription and tooling decisions. Targeting researchers by publication output, funding, and editorial activity is core to acquiring authors and growing analytics-product adoption.
$42B
The scientific software industry provides the digital infrastructure for modern research, from electronic lab notebooks to AI-driven drug discovery platforms. Growth is driven by the increasing computational intensity of research across all fields.
$627B
The semiconductor industry depends on a deep bench of academic device physicists and materials scientists to push past the limits of conventional scaling. Leading firms fund university cleanrooms, co-author with consortium labs, and compete aggressively for EE and solid-state-physics PhDs who can work on lithography, photonics, and advanced packaging. The talent pipeline from academic fabs is treated as a strategic asset.
$3.1B
Single-cell sequencing platforms resolve gene expression and chromatin accessibility at the individual cell level, transforming our understanding of tissue heterogeneity, development, and disease. Companies like 10x Genomics rely on academic developers of novel barcoding chemistries, microfluidics designs, and computational integration tools for new product development.
$630B
The commercial space sector spans launch, satellite manufacturing, Earth observation, and in-orbit servicing. It recruits academic scientists in propulsion, controls, and remote sensing, and partners with universities on small-satellite missions and instrument development.
$1.8B
Spatial transcriptomics preserves the tissue context of gene expression data, enabling researchers to map molecular heterogeneity within intact tissues. Instrument companies partner with academic pathology and genomics departments to develop clinical FFPE workflows, tumor microenvironment atlases, and computational tools for spatial data interpretation.
$890B
Specialty chemicals companies develop high-value functional materials for electronics, coatings, adhesives, personal care, and industrial applications. They rely on academic synthetic chemistry and physical chemistry groups for novel molecule development, catalyst discovery, and formulation science.
$7.4B
Sports science and human performance companies develop wearable sensors, monitoring platforms, and performance analytics tools used by professional sports teams, military units, and elite training programs. University exercise physiology and biomechanics departments provide the foundational physiology research and sensor validation studies that commercial platforms incorporate into their product development.
$3.4B
Structural biology CROs provide X-ray, cryo-EM, and NMR structure determination services to drug discovery programs, enabling structure-based lead optimization. University structural biology departments are primary sources of GPCR, kinase, and protease structures that form the basis of fragment-based drug discovery campaigns.
$130B
Surface engineering companies apply coatings, treatments, and thin-film processes to enhance wear resistance, corrosion protection, thermal stability, and optical performance of components. Academic materials science groups develop novel plasma-assisted and sol-gel coating processes that companies license for industrial scale-up.
$55B
Synthetic biology manufacturers reprogram microorganisms to produce chemicals, materials, and therapeutics that traditional chemistry cannot deliver economically or sustainably. The industry is an applied extension of academic research in metabolic engineering, systems biology, and molecular genetics — disciplines that generate the majority of its technical workforce. Companies like Ginkgo Bioworks and Solugen recruit heavily from PhD programs, open-source consortia, and iGEM alumni networks. Academic intelligence platforms allow these companies to track publication activity around specific genetic circuits, promoter libraries, or biosensor designs, giving recruiting and business-development teams a first-mover advantage when novel academic discoveries are about to translate to industry.
$280B
Upstream oil and gas technology companies provide drilling, completion, production, and reservoir engineering services and tools to oil producers worldwide. Universities with petroleum engineering departments develop novel EOR chemistries, seismic interpretation algorithms, and subsurface simulation tools that service companies license for commercial deployment.
$70B
The vaccine industry was transformed by mRNA platforms and now pursues programmable, rapidly deployable immunizations. It maintains close ties to academic immunology and structural-biology labs, recruiting PhD scientists in antigen design and formulation.
$36B
Life sciences venture capital funds the translation of academic discoveries into companies. VC firms actively scout university labs for breakthrough technologies, recruit academic co-founders, and rely on researcher networks for scientific due diligence.
$54B
The animal health industry develops vaccines, pharmaceuticals, diagnostics, and feed additives for companion animals, livestock, and aquaculture, with strong parallels to human medicine under the One Health framework. University veterinary schools and agricultural research centers are key partners for livestock disease surveillance, novel vaccine platforms, and companion animal clinical trial networks.
$310B
Water technology addresses scarcity through advanced desalination, recycling, and treatment systems. It draws on academic membrane scientists and environmental engineers, often piloting university-developed processes at municipal and industrial scale.
Install the CLI and run your first search in under a minute. No account required to explore.
npx sci-buy@latest COPIED